Atlas Trials

Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLC

Clinical trial NCT03001609 · COMPLETED

Trial details

NCT number
NCT03001609
Sponsor
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2016-11-01
Primary completion
2017-08-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.